Free Trial
NYSE:PKI

Revvity 2/1/2022 Earnings Report

Revvity EPS Results

Actual EPS
$2.56
Consensus EPS
$2.15
Beat/Miss
Beat by +$0.41
One Year Ago EPS
$3.96

Revvity Revenue Results

Actual Revenue
$1.36 billion
Expected Revenue
$1.32 billion
Beat/Miss
Beat by +$47.02 million
YoY Revenue Growth
+0.70%

Revvity Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Revvity Earnings Headlines

What 9 Analyst Ratings Have To Say About Revvity
An $8 trillion-dollar discovery 17,000 ft underwater
A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.tc pixel
Revvity, Inc. (RVTY)
Revvity Inc PKI
See More Revvity Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Revvity? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Revvity and other key companies, straight to your email.

About Revvity

Revvity (NYSE:PKI), Inc provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics.? The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.

View Revvity Profile

More Earnings Resources from MarketBeat